Genflow Biosciences
Business Services · United Kingdom · 1-10 Employees
View Company Info for Free
Overview
Headquarters
6 Heddon St, London, Greater London, W1B...Phone Number
+32 477495881Website
www.genflowbio.comRevenue
-Stock Symbol
GENFIndustry
ZI Rank: 1
Signal Type
Jan
Feb
Mar
Apr
May
Jun
ZI Rank
1
1
1
1
1
1
About Genflow Biosciences
Genflow Biosciences Plc is a UKbased biotechnology firm focused on developing gene therapies that aim to slow or counteract the biological aging process. Its research centers on leveraging genetic variants linked to longevity to create novel therapeutic approaches intended to extend healthy lifespan and address agerelated conditions. From a thirdparty standpoint, the company is recognized as an innovator in longevity science, pursuing advanced biological interventions with potential applications in human and veterinary health, and gaining attention for its gene therapy platform and strategic research collaborations.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Genflow Biosciences your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Genflow Biosciences had a recent Job posting/layoffs
Genflow Biosciences, which may be a good buyer, showed buying intent in Masked Content Topic
Congratulate Masked Content for being promoted to Masked Content at Genflow Biosciences
Website visits: Recent activity has been detected on your website
Check out if Genflow Biosciences is spiking on competitors!
Check if Genflow Biosciences has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Genflow Biosciences has new funding data
Product Launch: Get notified when Genflow Biosciences launches new products
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Earning: See what the market has to say on Genflow Biosciences recently announced quarterly report
Recommended Actions
Reach out to Masked Content who joined Genflow Biosciences as Masked Content
Find more new buyers
Company Profile Activity
Activity Insights
Genflow Biosciences is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Genflow Biosciences is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Genflow Biosciences.
Genflow Biosciences financials insights
Gather financial insights about Genflow Biosciences, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2026
Stock/Share Issuance
$1.1M
Genflow Biosciences Tech Stack
A closer look at the technologies used by Genflow Biosciences
See more technologies
Genflow Biosciences News & Media
Genflow Biosciences raises £800,000 to fund gene therapy programmes
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5), the biotechnology company focused on gene therapies for age-related diseases, confirmed it has successfully raised £800,000 through a share subscription intended to advance its scientific programmes and strengthen its negotiating position...Genflow Biosciences confirms receipt of €4m grant installment - Yahoo Finance
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) has received the first instalment of its €4 million non-dilutive grant from Belgium’s Wallonia Region, a funding package designed to support a three-year development programme. The company said the grant will back ongoing work on its...Genflow Biosciences: AGM and partnership strategy - ICYMI
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) CEO Dr Eric Leire talked with Proactive about the company’s latest RNS regarding its upcoming AGM and the strategic rationale behind authorising the potential issuance of shares ahead of clinical partnership discussions. Leire addressed...Genflow Biosciences, KEFI Gold and Copper, Valereum, Seeing Machines, Arecor Therapeutics, S&U
Genflow Biosciences Ltd (LSE:GENF, OTCQB:GENFF, FRA:WQ5) is seeing some great early results from its clinical trial on aged dogs. Every treatment group outperformed the control in areas like muscle mass and quality of life, with no safety issues reported. KEFI Gold and Copper PLC (AIM:KEFI, OTC:KFFLF, FRA: KMSA) has officially locked in its full US$340 million dollar project financing for the Tulu Kapi project in Ethiopia. This milestone lets the team start full mobilisation at
Read more news
Top Business Services Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Genflow Biosciences
Sign Up For FreeTo access detailed company insights
Genflow Biosciences Plc is a UKbased biotechnology firm focused on developing gene therapies that aim to slow or counteract the biological aging process. Its research centers on leveraging genetic variants linked to longevity to create novel therapeutic approaches intended to extend healthy lifespan and address agerelated conditions. From a thirdpa... Read More
